June 2013
Volume 54, Issue 15
Jump To...
Free
ARVO Annual Meeting Abstract  |   June 2013
Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment: A Partner Clinic Experience
Kira Segal; Michelle Lee; Kristin Chapman; Mark Rosenblatt; Kimberly Sippel; Christopher Starr; Jessica Ciralsky; Weill Cornell Eye Associates
Author Affiliations & Notes
  • Kira Segal
    Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
  • Michelle Lee
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Kristin Chapman
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Mark Rosenblatt
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Kimberly Sippel
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Christopher Starr
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Jessica Ciralsky
    Ophthalmology, NewYork-Presbyterian, New York, NY
  • Footnotes
    Commercial Relationships Kira Segal, None; Michelle Lee, None; Kristin Chapman, None; Mark Rosenblatt, None; Kimberly Sippel, None; Christopher Starr, None; Jessica Ciralsky, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5485. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment: A Partner Clinic Experience
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Kira Segal, Michelle Lee, Kristin Chapman, Mark Rosenblatt, Kimberly Sippel, Christopher Starr, Jessica Ciralsky, Weill Cornell Eye Associates; Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment: A Partner Clinic Experience. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5485.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract
 
Purpose
 

PURPOSE: To evaluate demographics, clinical course, and outcomes of patients who received the PROSE device at a partner clinic.

 
Methods
 

METHODS: Retrospective chart review of 37 consecutive patients (66 eyes) fit with the PROSE device.

 
Results
 

RESULTS: Indications for PROSE treatment included ectasia in 17 eyes (25.8%) and ocular surface disease in 49 eyes (74.2%). The average follow-up time was 4.76 months (2.4-9.35). Visual acuity improved with the PROSE device a statistically significant amount (p=0.002). All patients had improved ocular symptoms and decreased reliance on topical lubricants.

 
Conclusions
 

CONCLUSIONS: PROSE is an effective treatment option for many patients with complex corneal diseases.

 
Keywords: 477 contact lens • 486 cornea: tears/tear film/dry eye • 574 keratoconus  
© 2013, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept